Timing the race of vaccination, new variants, and relaxing restrictions during COVID-19 pandemic

Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5 Ritchie, 2020, Coronavirus pandemic (COVID-19), Our World Data Acter, 2020, Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: A global health emergency, Sci. Total Environ., 730, 10.1016/j.scitotenv.2020.138996 Liu, 2020, Cluster infections play important roles in the rapid evolution of COVID-19 transmission: a systematic review, Int. J. Infect. Dis. 2020 Li, 2021, Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study, Lancet, 397, 398, 10.1016/S0140-6736(20)32657-X Voysey, 2021, Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK, Lancet, 397, 99, 10.1016/S0140-6736(20)32661-1 Polack, 2020, Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine, N. Engl. J. Med., 383, 2603, 10.1056/NEJMoa2034577 Baden, 2021, Efficacy and safety of the mR NA-1273 SARS-CoV-2 vaccine, N. Engl. J. Med., 384, 403, 10.1056/NEJMoa2035389 Davies, 2021, Estimated transmissibility and impact of SARS-CoV-2 lineage b.1.1.7 in England, Science, 372, 10.1126/science.abg3055 Ong, 2021, Clinical and virological features of SARS-CoV-2 variants of concern: a retrospective cohort study comparing B.1.1.7 (Alpha), B.1.315 (Beta), and B.1.617.2 (Delta), Clin. Infect. Dis. Salleh, 2021, Structural evaluation of the spike glycoprotein variants on SARS-CoV-2 transmission and immune evasion, Int. J. Mol. Sci., 22, 7425, 10.3390/ijms22147425 Sanches, 2021, Recent advances in SARS-CoV-2 spike protein and rbd mutations comparison between new variants Alpha (B.1.1.7, United Kingdom), Beta (b.1.351, South Africa), Gamma (p.1, Brazil) and delta (b.1.617.2, India), J. Virus Erad., 10.1016/j.jve.2021.100054 Hodcroft, 2021 Planas, 2021, Reduced sensitivity of SARS-CoV-2 variant delta to antibody neutralization, Nature, 596, 276, 10.1038/s41586-021-03777-9 Dougherty, 2021, Sars-CoV-2 b.1.617.2 (delta) variant COVID-19 outbreak associated with a gymnastics facility—Oklahoma, April–May 2021, Morb. Mortal. Wkly. Rep., 70, 1004, 10.15585/mmwr.mm7028e2 2020 Caetano, 2021, Mathematical modelling of the impact of non-pharmacological strategies to control the COVID-19 epidemic in Portugal, Mathematics, 9, 1084, 10.3390/math9101084 Sarkar, 2020, Modeling and forecasting the COVID-19 pandemic in India, Chaos Solitons Fractals, 139, 10.1016/j.chaos.2020.110049 Makhoul, 2020, Epidemiological impact of SARS-CoV-2 vaccination: Mathematical modeling analyses, Vaccines, 8, 668, 10.3390/vaccines8040668 Borse, 2013, Effects of vaccine program against pandemic influenza A (H1N1) virus, United States, 2009–2010, Emerg. Infect. Diseases, 19, 439, 10.3201/eid1903.120394 Nguyen, 2016, Optimizing real-time vaccine allocation in a stochastic SIR model, PLoS One, 11, 10.1371/journal.pone.0152950 Reis, 2020, Characterization of the COVID-19 pandemic and the impact of uncertainties, mitigation strategies, and underreporting of cases in South Korea, Italy, and Brazil, Chaos Solitons Fractals, 136, 10.1016/j.chaos.2020.109888 Tulu, 2017, Modeling the effect of quarantine and vaccination on Ebola disease, Adv. Difference Equ., 2017, 1, 10.1186/s13662-017-1225-z Lin, 2010, An optimal control theory approach to non-pharmaceutical interventions, BMC Infect. Dis., 10, 1, 10.1186/1471-2334-10-32 Gaudart, 2010, Demography and diffusion in epidemics: malaria and black death spread, Acta Biotheor., 58, 277, 10.1007/s10441-010-9103-z Furushima, 2017, Estimation of the basic reproduction number of novel influenza A (H1N1) pdm09 in elementary schools using the SIR model, Open Nurs. J., 11, 64, 10.2174/1874434601711010064 Reis, 2021, The quixotic task of forecasting peaks of COVID-19:: Rather focus on forward and backward projections, Front. Public Health, 9, 168, 10.3389/fpubh.2021.623521 Oliveira, 2021, How fast vaccination can control the COVID-19 pandemic in Brazil?, 497 Diekmann, 2000 Hethcote, 2000, The mathematics of infectious diseases, SIAM Rev., 42, 599, 10.1137/S0036144500371907 Kermack, 1927, A contribution to the mathematical theory of epidemics, Proc. R. Soc. Lond. Ser. A, 115, 700, 10.1098/rspa.1927.0118 Kermack, 1991, Contributions to the mathematical theory of epidemics—I, Bull. Math. Biol., 53, 33 Keeling, 2011 Harris, 2021, Impact of vaccination on household transmission of SARS-CoV-2 in England, MedRxiv R. Araos, Efectividad de la Vacuna CoronaVac Con Virus Inactivo Contra SARS-CoV-2 en Chile, Preliminary Report, 2021, URL. Lopez Bernal, 2021, Effectiveness of the pfizer-BioNTech and oxford-AstraZeneca vaccines on COVID-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study, BMJ, 373 Storn, 1997, Differential evolution–a simple and efficient heuristic for global optimization over continuous spaces, J. Global Optim., 11, 341, 10.1023/A:1008202821328 Lei, 2020, Considering discrepancy when calibrating a mechanistic electrophysiology model, Phil. Trans. R. Soc. A, 378, 10.1098/rsta.2019.0349 2020 Dolgin, 2021, Covid vaccine immunity is waning-how much does that matter, Nature, 597, 606, 10.1038/d41586-021-02532-4 Faria, 2021, Genomics and epidemiology of the p.1 SARS-CoV-2 lineage in manaus, Brazil, Science, 372, 815, 10.1126/science.abh2644